Figure 8 CMFDA applications in the subpallium demonstrate tangentially migrating Nkx2.1 and GABAergic cells. Transverse sections through the developing telencephalon. After combined CMFDA and immunolabeling for Nkx2.1 (a,d) and GABA (c, e–i), double-labeled cells (arrowheads) were detected leaving the application area. In (b, e, g) boxes indicate enlarged area in the next panel. Arrowheads in (b) and (e) indicate CMFDA cells out of the injection site. Scale bars ¼ 100 lm (a, b, d, e, g, i) and 25 lm (c, f, h).
Image published in: Moreno N et al. (2008)
Copyright © 2008. Image reproduced with permission of the Publisher, John Wiley & Sons.
Permanent Image Page
Printer Friendly View
XB-IMG-130336